By adding behavioral components to an infectious disease model, Brown University researchers have developed a new modeling approach that captures the peaks and valleys in new COVID-19 cases seen over the past 16 months.
Jun 11, 2021
0
3
People who look to social media for information, particularly YouTube, are less willing to be vaccinated against COVID-19, according to a new publication from the universities of Oxford and Southampton whose researchers are ...
Jun 3, 2021
0
2
Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or ...
May 14, 2021
1
47
The European Union has not renewed orders for AstraZeneca's COVID-19 vaccine beyond June and is not certain that it will, the bloc's internal market commissioner said Sunday.
May 9, 2021
0
4
A quarter of the European Union's population have received at least one COVID-19 vaccine jab, prompting EU chief Ursula von der Leyen to say the bloc is on track to have 70 percent of adults immunised by late July.
May 4, 2021
0
3
British pharmaceuticals giant AstraZeneca said Friday that its COVID vaccine generated $275 million (227 million euros) in sales in the first quarter, as its chief executive defended the company's performance in the face ...
Apr 30, 2021
0
5
The European Union and AstraZeneca will begin their oral arguments on May 26 in the bloc's legal action against the pharmaceutical giant over coronavirus vaccine shortfalls, a Belgian court said Wednesday.
Apr 28, 2021
0
2
The European Union said Monday it has launched legal action against pharmaceutical giant AstraZeneca over coronavirus vaccine delivery shortfalls that hampered efforts to kickstart inoculations across the bloc.
Apr 26, 2021
0
1
Chancellor Angela Merkel on Saturday defended a fiercely-opposed new law imposing tough coronavirus restrictions across Germany including night curfews and school closures.
Apr 24, 2021
0
9
The EU's drug watchdog said Friday that a review of AstraZeneca's COVID-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.
Apr 23, 2021
0
5
